Literature DB >> 31689519

Phloretin ameliorates dextran sulfate sodium-induced ulcerative colitis in mice by regulating the gut microbiota.

Minna Wu1, Puze Li2, Yunying An2, Jie Ren2, Dong Yan2, Jiazeng Cui3, Duan Li2, Min Li2, Mingyong Wang4, Genshen Zhong5.   

Abstract

Phloretin, extracted from the pericarp and velamen of apples or pears, is a dihydrochalcone flavonoid with anti-bacterial and anti-inflammatory activities. It has been reported that phloretin has anti-inflammatory effects in ulcerative colitis (UC) mice. However, the role of the gut microbiota in the phloretin anti-UC process remains unclear. In this study, we observed that the anti-UC effect of phloretin was affected by co-housing, probably because of the transmissible nature of the gut micobiota. Through fecal micobiota transplantation (FMT), the effects of the gut microbiota on the anti-UC of phloretin were further confirmed. UC was induced in mice by administrating 3% dextran sulfate sodium (DSS) in drinking water for 7 days. Phloretin (60 mg/kg) was administered by gavage every day during the experiment. Fecal microbes (109 CFU/mL) from phloretin-treated UC mice were administered by gavage to non-phloretin-treated UC mice for 7 days. The results showed that FMT, like phloretin, ameliorated UC by improving disease symptoms and colon inflammation, balancing inflammatory cytokines, maintaining intestinal barrier integrity, restoring systemic immune function, inhibiting NF-κB and NLRP3 inflammasome activation and ameliorating the oxidant stress. Both FMT and phloretin treatment increased the levels of Bacteroidetes, Alistipes and Lactobacillus and decreased those of Firmicutes, Oscillibacter and Ruminiclostridium_6. Correlation analysis between gut microbes and micro-environmental factors revealed that Alistipes abundance was negatively correlated with DAI, pathological score, and TNF-α, IL-6 and IL-1β levels, and Alistipes was more abundant in phloretin or FMT treated UC mice. Oscillibacter abundance was significantly positively correlated with IL-6 and IL-1β levels and pathological score, and Oscillibacter was increased in UC mice. Furthermore, network analysis of the dominant genera revealed that Alistipes abundance was negatively related to Oscillibacter abundance. In conclusion, this study suggests that the anti-UC effects of phloretin are achieved through regulation of the gut microbiota and phloretin has the potential to be developed as a promising agent for the treatment of UC.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Gut microbiota; Immune function; Intestinal barrier; Phloretin; Ulcerative colitis

Mesh:

Substances:

Year:  2019        PMID: 31689519     DOI: 10.1016/j.phrs.2019.104489

Source DB:  PubMed          Journal:  Pharmacol Res        ISSN: 1043-6618            Impact factor:   7.658


  31 in total

1.  Efficacy of faecal microbiota transplantation on ulcerative colitis and its effect on gastrointestinal motility and immune function.

Authors:  Dengshun Lei; Hong Xu; Renqun Peng; Mei Yang; Xinghui Li; Wei Zuo; Juhua Gou; Shuangjiang Yu; Min Huang; Hao Liu
Journal:  Am J Transl Res       Date:  2021-12-15       Impact factor: 4.060

2.  Yishen Qingli Heluo Granule Ameliorates Renal Dysfunction in 5/6 Nephrectomized Rats by Targeting Gut Microbiota and Intestinal Barrier Integrity.

Authors:  Xian Sun; Jie Chen; Yiting Huang; Sha Zhu; Shuaishuai Wang; Zijing Xu; Junfeng Zhang; Wei Sun
Journal:  Front Pharmacol       Date:  2022-06-22       Impact factor: 5.988

3.  Phloretin Protects Bovine Rumen Epithelial Cells from LPS-Induced Injury.

Authors:  Kexin Wang; Qian Lei; Huimin Ma; Maocheng Jiang; Tianyu Yang; Qianbo Ma; Osmond Datsomor; Kang Zhan; Guoqi Zhao
Journal:  Toxins (Basel)       Date:  2022-05-11       Impact factor: 5.075

4.  Ursolic acid restores sensitivity to gemcitabine through the RAGE/NF-κB/MDR1 axis in pancreatic cancer cells and in a mouse xenograft model.

Authors:  Zih-Ying Li; Sheng-Yi Chen; Ming-Hong Weng; Gow-Chin Yen
Journal:  J Food Drug Anal       Date:  2021-06-15       Impact factor: 6.157

5.  Bletilla striata Oligosaccharides Improve Ulcerative Colitis by Regulating Gut Microbiota and Intestinal Metabolites in Dextran Sulfate Sodium-Induced Mice.

Authors:  Tianxiang Zhu; Baifei Hu; Cheng Ye; Haiming Hu; Mingzhu Yin; Zhigang Zhang; Shuiqing Li; Yanju Liu; Hongtao Liu
Journal:  Front Pharmacol       Date:  2022-04-25       Impact factor: 5.988

6.  Integrating Pharmacology and Microbial Network Analysis with Experimental Validation to Reveal the Mechanism of Composite Sophora Colon-Soluble Capsule against Ulcerative Colitis.

Authors:  Yuxuan Ding; Mingjun Chen; Qiying Wang; Lu Gao; Yang Feng; Shida Wang; Zitian Song; Zhanqi Tong
Journal:  Evid Based Complement Alternat Med       Date:  2020-04-20       Impact factor: 2.629

7.  Barley Leaf Insoluble Dietary Fiber Alleviated Dextran Sulfate Sodium-Induced Mice Colitis by Modulating Gut Microbiota.

Authors:  Meiling Tian; Daotong Li; Chen Ma; Yu Feng; Xiaosong Hu; Fang Chen
Journal:  Nutrients       Date:  2021-03-05       Impact factor: 5.717

8.  Acyloxyacyl hydrolase is a host determinant of gut microbiome-mediated pelvic pain.

Authors:  Afrida Rahman-Enyart; Wenbin Yang; Ryan E Yaggie; Bryan A White; Michael Welge; Loretta Auvil; Matthew Berry; Colleen Bushell; John M Rosen; Charles N Rudick; Anthony J Schaeffer; David J Klumpp
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2021-07-28       Impact factor: 3.210

Review 9.  Gut microbiota alterations are distinct for primary colorectal cancer and hepatocellular carcinoma.

Authors:  Wei Jia; Cynthia Rajani; Hongxi Xu; Xiaojiao Zheng
Journal:  Protein Cell       Date:  2020-08-14       Impact factor: 14.870

10.  Total Flavone of Abelmoschus manihot Ameliorates Stress-Induced Microbial Alterations Drive Intestinal Barrier Injury in DSS Colitis.

Authors:  Rong Wang; Tuo Chen; Qiong Wang; Xiao-Min Yuan; Zheng-Lan Duan; Ze-Yu Feng; Yang Ding; Fan Bu; Guo-Ping Shi; Yu-Gen Chen
Journal:  Drug Des Devel Ther       Date:  2021-07-08       Impact factor: 4.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.